What is a stock summary page? Click here for an overview.
Business Description
Natera Inc
NAICS : 621511
SIC : 8071
ISIN : US6323071042
Description
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.18 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | -1.26 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 25.97 | |||||
| Beneish M-Score | -2.67 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 25.4 | |||||
| 3-Year EBITDA Growth Rate | 38 | |||||
| 3-Year EPS without NRI Growth Rate | 33.5 | |||||
| 3-Year Book Growth Rate | 9.5 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 16.44 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.78 | |||||
| 9-Day RSI | 60.79 | |||||
| 14-Day RSI | 56.4 | |||||
| 3-1 Month Momentum % | -8.22 | |||||
| 6-1 Month Momentum % | 29.08 | |||||
| 12-1 Month Momentum % | 68.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4 | |||||
| Quick Ratio | 3.87 | |||||
| Cash Ratio | 2.81 | |||||
| Days Inventory | 23.65 | |||||
| Days Sales Outstanding | 65.56 | |||||
| Days Payable | 14.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.7 | |||||
| Shareholder Yield % | 0.28 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.3 | |||||
| Operating Margin % | -13.1 | |||||
| Net Margin % | -11.22 | |||||
| FCF Margin % | 3.46 | |||||
| ROE % | -21.3 | |||||
| ROA % | -12.4 | |||||
| ROIC % | -45.39 | |||||
| 3-Year ROIIC % | 91.88 | |||||
| ROC (Joel Greenblatt) % | -47.68 | |||||
| ROCE % | -14.66 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 11.4 | |||||
| PB Ratio | 17.15 | |||||
| Price-to-Tangible-Book | 17.15 | |||||
| Price-to-Free-Cash-Flow | 336.82 | |||||
| Price-to-Operating-Cash-Flow | 143.78 | |||||
| EV-to-EBIT | -107.81 | |||||
| EV-to-Forward-EBIT | -63.87 | |||||
| EV-to-EBITDA | -130.35 | |||||
| EV-to-Forward-EBITDA | -76.03 | |||||
| EV-to-Revenue | 11.37 | |||||
| EV-to-Forward-Revenue | 9.95 | |||||
| EV-to-FCF | 328.57 | |||||
| Price-to-GF-Value | 1.69 | |||||
| Price-to-Median-PS-Value | 1.97 | |||||
| Price-to-Net-Current-Asset-Value | 22.52 | |||||
| Price-to-Net-Cash | 40.76 | |||||
| Earnings Yield (Greenblatt) % | -0.93 | |||||
| FCF Yield % | 0.28 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NTRA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Natera Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,696.911 | ||
| EPS (TTM) ($) | -1.53 | ||
| Beta | 1.85 | ||
| 3-Year Sharpe Ratio | 0.95 | ||
| 3-Year Sortino Ratio | 2.1 | ||
| Volatility % | 49.2 | ||
| 14-Day RSI | 56.4 | ||
| 14-Day ATR ($) | 8.072361 | ||
| 20-Day SMA ($) | 144.6095 | ||
| 12-1 Month Momentum % | 68.12 | ||
| 52-Week Range ($) | 87.2 - 183 | ||
| Shares Outstanding (Mil) | 135.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Natera Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Natera Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Natera Inc Frequently Asked Questions
What is Natera Inc(NTRA)'s stock price today?
The current price of NTRA is $154.48. The 52 week high of NTRA is $183.00 and 52 week low is $87.20.
When is next earnings date of Natera Inc(NTRA)?
The next earnings date of Natera Inc(NTRA) is 2025-05-09 Est..
Does Natera Inc(NTRA) pay dividends? If so, how much?
Natera Inc(NTRA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers